Pfizer Inc, has released promising top-line data for its Abrysvo vaccine, demonstrating high efficacy against respiratory syncytial virus (RSV) in adults aged 60 and older. These findings from the Phase 3 clinical trial hold significant implications for infection control personnel working to combat RSV infections, especially in vulnerable populations.
Sharon Ward-Fore, MS, BS, MT(ASCP), CIC, FAPIC, honored with the Infection Control Today Educator of the Year Award™ streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The award celebrates the outstanding achievements of an infection prevention and control professional who excels and demonstrates a passion for educating.
Sharon Ward-Fore, MS, BS, MT(ASCP), CIC, FAPIC, honored with the Infection Control Today Educator of the Year Award™ businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.